This meant an analysis could be carried out on the combined data, which established an odds ratio of 12.97 (with 95% confidence limits of 5.14–32.68) and P < 0.00001, indicating that IgE autoantibodies are significantly more likely to be identified in patients with AD compared to the control groups (Fig. 2). Here, IGHE is linked to Alzheimer disease.